TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases
- PMID: 9620642
- DOI: 10.1016/s1359-6101(97)00018-x
TGF-beta in the central nervous system: potential roles in ischemic injury and neurodegenerative diseases
Abstract
The Transforming Growth Factor-betas (TGF-beta) are a group of multifunctional proteins whose cellular sites of production and action are widely distributed throughout the body, including the central nervous system (CNS). Within the CNS, various isoforms of TGF-beta are produced by both glial and neural cells. When evaluated in either cell culture or in vivo models, the various isoforms of TGF-beta have been shown to have potent effects on the proliferation, function, or survival of both neurons and all three glial cell types, astrocytes, microglia and oligodendrocytes. TGF-beta has also been shown to play a role in several forms of acute CNS pathology including ischemia, excitotoxicity and several forms of neurodegenerative diseases including multiple sclerosis, Parkinson's disease, AIDS dementia and Alzheimer's disease.
Similar articles
-
Transforming growth factor-betas in neurodegenerative disease.Prog Neurobiol. 1998 Jan;54(1):71-85. doi: 10.1016/s0301-0082(97)00066-x. Prog Neurobiol. 1998. PMID: 9460794 Review.
-
Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia.Cold Spring Harb Perspect Biol. 2014 Dec 4;7(3):a020602. doi: 10.1101/cshperspect.a020602. Cold Spring Harb Perspect Biol. 2014. PMID: 25475091 Free PMC article. Review.
-
Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.J Neuropathol Exp Neurol. 1999 Feb;58(2):174-87. doi: 10.1097/00005072-199902000-00007. J Neuropathol Exp Neurol. 1999. PMID: 10029100
-
Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome.J Exp Med. 1991 Apr 1;173(4):981-91. doi: 10.1084/jem.173.4.981. J Exp Med. 1991. PMID: 2007861 Free PMC article.
-
The role of dendritic cells in neurodegenerative diseases.Arch Immunol Ther Exp (Warsz). 2002;50(3):187-96. Arch Immunol Ther Exp (Warsz). 2002. PMID: 12098934 Review.
Cited by
-
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus.Arthritis Res Ther. 2004;6(2):R129-36. doi: 10.1186/ar1040. Epub 2004 Jan 22. Arthritis Res Ther. 2004. PMID: 15059276 Free PMC article.
-
Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway.J Neurosci. 2001 May 1;21(9):3024-33. doi: 10.1523/JNEUROSCI.21-09-03024.2001. J Neurosci. 2001. PMID: 11312287 Free PMC article.
-
Age and sex differences in primary microglia culture: A comparative study.J Neurosci Methods. 2021 Dec 1;364:109359. doi: 10.1016/j.jneumeth.2021.109359. Epub 2021 Sep 17. J Neurosci Methods. 2021. PMID: 34537225 Free PMC article.
-
Decoding Mast Cell-Microglia Communication in Neurodegenerative Diseases.Int J Mol Sci. 2021 Jan 22;22(3):1093. doi: 10.3390/ijms22031093. Int J Mol Sci. 2021. PMID: 33499208 Free PMC article. Review.
-
Propolis ameliorates cerebral injury in focal cerebral ischemia/reperfusion (I/R) rat model via upregulation of TGF-β1.Saudi Pharm J. 2020 Jan;28(1):116-126. doi: 10.1016/j.jsps.2019.11.013. Epub 2019 Dec 7. Saudi Pharm J. 2020. PMID: 31920438 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical